financial results
CareDx Raises Full-Year Guidance as Q3 Revenues Grow 23 Percent
Quarterly revenue gains were driven by a 27 percent year-over-year increase in testing services revenue.
Hologic Revenues Rise 5 Percent on Strength of Molecular Diagnostics Business
The firm reported a 13 percent jump in its non-COVID molecular diagnostics revenues year over year while its breast health and GYN Surgical business revenues rose 6 percent.
The firm's Q3 2024 revenues rose 33 percent year over year as both its genomics and data and services revenues increased in the double-digit percent range.
China Instrument Sales Drag on Revvity Life Science Segment as Company Q3 Revenues Rise 2 Percent
Premium
Similar to other firms, the firm said that it has been negatively impacted as customers in China wait for government stimulus funding to arrive.
Biodesix Q3 Revenues up 35 Percent
The company attributed its growth to increased adoption of its lung cancer risk assessment tests, while it highlighted recent and ongoing research supporting those products.